This inventor holds 18 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Solazyme, Inc., Corbion Biotech, Inc., Terravia Holdings, Inc.. Active years: 2013-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
9 out of 63 
6 out of 42 
3 out of 19 Years Active: 2013-2020
Title: The Innovative Contributions of Jeffrey L. Moseley in Biotechnology
Introduction
Jeffrey L. Moseley, an accomplished inventor based in Redwood City, CA, has made significant contributions to the field of biotechnology through his innovative work. With a portfolio that includes 18 patents, his research has focused on enhancing enzymatic processes and the development of renewable chemicals, particularly through advancements in thioesterases.
Latest Patents
One of Jeffery L. Moseley's latest patents is centered around variant thioesterases and their applications in increasing the enzymatic activity in plants. This invention specifically promotes the production of mid-chain length fatty acids, ranging from 8 to 14 carbon atoms, in desired ratios. Additionally, it outlines methods to manufacture renewable chemicals from novel triglyceride oils, which undergo chemical modifications for various applications. The oils produced, containing fatty acids of chain lengths C8, C10, C12, or C14, serve as valuable feedstocks for the processes he describes.
Career Highlights
Throughout his career, Jeffrey has aligned himself with prominent companies within the biotechnology sector. He has played vital roles at Solazyme, Inc. and Corbion Biotech, Inc., both of which are known for their innovative approaches to bioengineering and sustainable chemical production. His work at these companies has significantly contributed to advances in renewable materials and agricultural biotechnologies.
Collaborations
Collaboration has been key to Jeffrey L. Moseley’s accomplishments. He has worked with notable colleagues such as Scott Franklin and Aravind Somanchi, whose combined expertise has allowed for fruitful advancements in the fields of enzymatic activity and biochemical engineering.
Conclusion
Jeffrey L. Moseley continues to push the boundaries of biotechnological innovation through his inventive spirit and collaborative efforts. His patents, particularly in the field of variant thioesterases, exemplify his commitment to fostering sustainable solutions and enhancing biological processes, marking him as a distinguished figure in the landscape of modern invention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile